Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Jul;74(7):2751-5.
doi: 10.1073/pnas.74.7.2751.

Glycophorin and the concanavalin A receptor of human erythrocytes: their receptor function in lipid bilayers

Glycophorin and the concanavalin A receptor of human erythrocytes: their receptor function in lipid bilayers

F J Sharom et al. Proc Natl Acad Sci U S A. 1977 Jul.

Abstract

Two integral glycoproteins from the human erythrocyte have been studied after their incorporation into lipid bilayer systems. Glycophorin (which is the M/N blood group determinant) and the concanavalin A receptor were isolated and purified prior to incorporation into model membranes by dialytic removal of detergent from lipid/protein solutions. Under the conditions described, glycoprotein receptors maintain their function in that they bind external agents specific for them, such as concanavalin A and immunoglobulins. So-called intramembranous particles are a feature of freeze-fractured preparations of lipid bilayers containing either (or both) glycoprotein(s), and to some extent each has a characteristic particle appearance. Liposomes containing the concanavalin A receptor (with or without glycophorin) are agglutinable by concanavalin A, whereas human erythrocytes are normally considered to be nonagglutinable by this lectin. Liposomes containing glycophorin alone are readily agglutinable by the appropriate glycophorin-directed M/N antiserum, as are human erythrocytes. The added presence of concanavalin A receptor in the liposomes can markedly inhibit agglutination by M/N antiserum without preventing immunoglobulin binding.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochim Biophys Acta. 1977 Mar 1;465(2):191-7 - PubMed
    1. Arch Biochem Biophys. 1963 Jan;100:119-30 - PubMed
    1. Proc Natl Acad Sci U S A. 1976 Nov;73(11):3891-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3497-501 - PubMed
    1. Biochim Biophys Acta. 1976 Nov 11;455(1):1-7 - PubMed

LinkOut - more resources